Chaired by Livia Edegger, Deputy Director of the International Society of Substance Use Professionals (ISSUP), the specialist in this panel spoke about the importance of creating and strengthening the workface in drug demand reduction...
The Canadian Centre for Substance Use and Addiction (CCSA) in partnership with the Royal Ottawa Mental Health Centre, the Canadian Psychological Association and Canada Health Infoway, collected national data on the experience and...
One of the most serious public health concerns in recent decades has been the opioid epidemic in the United States (US). Over 9.9 million Americans aged 12 and up abused prescription pain drugs in 2018, and roughly 2 million Americans were...
The U.S. Department of State's Bureau of International Narcotics and Law Enforcement Affairs (INL) presents the third annual event on partnering with the private sector to address the world drug problem. The private sector can play a major...
This publication provides a practical introduction to the area of quality standards and quality assurance mechanisms and the key steps involved in their implementation in drug services and systems.
The Alcoholics Anonymous (AA) movement created the term "in recovery" to express the continuing requirement for vigilance in order to sustain sobriety (which includes abstinence from alcohol intake) and avoid a return to dangerous drinking...
The use of alcohol and drugs is a significant public health concern and is prevalent in families. Over 100 million people are thought to be affected by a close relative's substance use, with many experiencing negative health and social...
The UNODC Regional Office for West and Central Africa (ROSEN) and the Prevention, Treatment and Rehabilitation Section in Vienna (PTRS), organized from June 14th to June 18th, an online Quality Assurance training, benefitting 16 drug...
The EU Strategy 2021-2025 puts further emphasis on QS and evidence-based interventions. Yet, the extent and ways in which QS are implemented in daily practices of drug prevention, treatment and harm reduction in the EU varies substantially...